Insulet Corporation - Common Stock (NQ:PODD)

149.68 -2.82 (-1.85%)

Delayed Quote Updated: 4:00 PM EDT, Oct 30, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Insulet Corporation - Common Stock

< Previous 1 2

...

21 22 23 24 25 26 27 28 Next >

Insulet’s Omnipod® 5 Pivotal Study Extension Data Shows Significant Improvements in Glycemic Control With One Year of Use

September 30, 2021

From Insulet Corporation

Via Business Wire

Insulet to Announce Third Quarter 2021 Financial Results on November 4, 2021

September 29, 2021

From Insulet Corporation

Via Business Wire

5 Top Stocks for September ↗

September 11, 2021

Our analysts give you five picks you can add to your portfolio today.

Via The Motley Fool

Earnings Scheduled For May 6, 2021 ↗

May 06, 2021

Companies Reporting Before The Bell • ViacomCBS (NASDAQ:VIAC) is projected to report quarterly earnings at $1.22 per share on revenue of $7.30 billion. • Cohen...

Via Benzinga

Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge ↗

May 01, 2021

Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name...

Via Benzinga

The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization ↗

September 09, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 8) Abbott Laboratories (NYSE:...

Via Benzinga

Insulet to Present at Upcoming Investor Conferences

August 26, 2021

From Insulet Corporation

Via Business Wire

The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod ↗

September 08, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 7) Adial Pharmaceuticals, Inc...

Via Benzinga

Looking into Insulet's Return on Capital Employed ↗

August 23, 2021

After pulling data from Benzinga Pro it seems like during Q2, Insulet (NASDAQ:PODD) earned $26.30 million, a 61.35% increase from the preceding quarter. Insulet also posted a...

Via Benzinga

FDA Clears Use Of Eli Lilly's Insulin With Insulet's Infusion Pumps ↗

August 16, 2021

The

Via Benzinga

Insulet Announces FDA Clearance of Lyumjev® Rapid-Acting Insulin for Use with Omnipod® Products in the United States

August 16, 2021

From Insulet Corporation

Via Business Wire

Insulet Introduces Omnipod DASH® System at Australasian Diabetes Congress

August 11, 2021

From Insulet Corporation

Via Business Wire

Insulet Stock Dives On Unexpected Delay For Next-Generation Insulin Pump ↗

August 06, 2021

Insulet said Thursday it expects a one-quarter delay for its next-generation insulin pump, leading PODD stock to tumble on Friday.

Via Investor's Business Daily

Insulet Corporation (PODD) Q2 2021 Earnings Call Transcript ↗

August 06, 2021

PODD earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

Insulet Reports Second Quarter 2021 Revenue Increase of 16% Year-Over-Year

August 05, 2021

From Insulet Corporation

Via Business Wire

3 Stocks to Buy That Should Get a Boost From Pandemic-Driven Consumer Weight Gain ↗

July 31, 2021

Athletic-apparel maker Lululemon and two diabetes specialists are poised to get a long-term tailwind from the COVID-19 pandemic.

Via The Motley Fool

Insulet to Present at Upcoming Investor Conferences

July 26, 2021

From Insulet Corporation

Via Business Wire

Insulet to Announce Second Quarter 2021 Financial Results on August 5, 2021

July 01, 2021

From Insulet Corporation

Via Business Wire

Insulet’s Omnipod® 5 Automated Insulin Delivery System Pivotal Studies Demonstrate Improved Outcomes Across the Lifespan from Ages 2 to 70 years

June 26, 2021

From Insulet Corporation

Via Business Wire

Insulet to Present New Clinical Data for Preschool Children and Adults using the Omnipod® 5 System

June 24, 2021

From Insulet Corporation

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For May 25, 2021 ↗

May 25, 2021

Upgrades For Appian Corp (NASDAQ:APPN), Macquarie upgraded the previous rating of Underperform to Neutral. For the first quarter, Appian had an EPS of $0.06, compared to...

Via Benzinga

Insulet Corp (PODD) Q1 2021 Earnings Call Transcript ↗

May 07, 2021

PODD earnings call for the period ending March 31, 2021.

Via The Motley Fool

Topics Earnings

Insulet Reports First Quarter 2021 Revenue Increase of 27% Year-Over-Year

May 06, 2021

From Insulet Corporation

Via Business Wire

Insulet to Present at BofA Securities 2021 Virtual Healthcare Conference

May 04, 2021

From Insulet Corporation

Via Business Wire

Insulet 2020 Sustainability Report Conveys Strategy to Deliver Growth with Purpose

May 03, 2021

From Insulet Corporation

Via Business Wire

The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom ↗

May 06, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 5) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

The Daily Biotech Pulse: Hyperphosphatemia Drug Regulatory Review Extended, Phathom Pharma Data Readout, 2 IPOs ↗

April 30, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 29) AtriCure, Inc. (NASDAQ:...

Via Benzinga

Insulet Announces Pricing of New Senior Secured Credit Facilities

April 29, 2021

From Insulet Corporation

Via Business Wire

The Daily Biotech Pulse: Clinical Setback For Adverum, Galera Posts Data Readout, Moderna To Invest In Vaccine Manufacturing, Decision Day For Ardelyx ↗

April 29, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 28) Axonics, Inc. (NASDAQ:...

Via Benzinga

The Daily Biotech Pulse: FDA Rejection For Protalix, Amgen Q1 Trail Estimates, Pfizer Goes Shopping ↗

April 28, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 27) Aldeyra Therapeutics, Inc...

Via Benzinga

< Previous 1 2

...

21 22 23 24 25 26 27 28 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.